ASIA-PACIFIC APHERESIS MARKET FORECAST 2021-2028

The Asia-Pacific apheresis market is estimated to project a CAGR of 9.05% during the forecast period, 2021-2028. The rising number of accident cases and diseases and technological advancements are the primary growth drivers.

asia-pacific-apheresis-market

 The Asia-Pacific apheresis market growth assessment includes the analysis of India, Australia & New Zealand, Vietnam, Thailand, South Korea, Japan, China, Indonesia, and Rest of Asia-Pacific. China is one of the major consumers and manufacturers of global plasma-derived products. Plasma-derived and blood products are considered strategic resources in the country. Also, the plasma fractionation industry has been making significant progress in the last 50 years. As per Liu Zhihua, as of 2019, almost 21.3% of diabetic patients have chronic kidney disease, set to increase further in the coming years. Further, the five-year survival rates of lymphoma and leukemia are 37% and 25%, respectively. The treatment process of such diseases requires apheresis, which is set to boost market growth. Also, there is a growing need for blood processing with increased blood donation. Moreover, major market players in cancer immunotherapy are collaborating with other companies to propel their R&D activities. Such factors are driving the market growth in China.

In Thailand, blood shortage was observed in the Thai Red Cross Society during the COVID-19 pandemic, with people not willing to leave their homes. Also, there was a drop rate of 50% blood donors in the National Blood Centre. Moreover, Lipoprotein Apheresis is done weekly or biweekly to sustain healthy cholesterol levels in cardiac patients. As per the Ministry of Public Health reports, there are almost 15,000 thalassemia patients with severe symptoms requiring blood transfusion twice every month. Such factors are leading to surging blood demands, which impacts the market growth.

Kaneka Corporation is an international chemical manufacturing company based in Japan. The health care solutions unit of the company provides medical devices like blood purification products, cell therapy, regenerative medicine, ophthalmological products, etc. It has operations in the Americas, Asia, Africa, Oceania, Japan, and Europe, with headquarters in Minato City, Tokyo, Japan.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
      2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
      3. GROWING GERIATRIC POPULATION
    2. KEY RESTRAINTS
      1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
      2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS IN DEVELOPING AND UNDERDEVELOPED COUNTRIES
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON APHERESIS MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRY
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY PROCEDURE
    1. PLASMAPHERESIS
    2. PLATELETPHERESIS
    3. LEUKAPHERESIS
    4. ERYTHROCYTAPHERESIS
    5. OTHER APHERESIS PROCEDURES
  6. MARKET BY TECHNOLOGY
    1. CENTRIFUGATION
    2. MEMBRANE SEPARATION
  7. MARKET BY PRODUCT
    1. DISPOSABLE APHERESIS KITS
    2. APHERESIS MACHINE
  8. MARKET BY APPLICATION
    1. HEMATOLOGICAL DISORDERS
    2. NEUROLOGICAL DISORDERS
    3. AUTOIMMUNE DISORDERS
    4. RENAL DISORDERS
    5. OTHER APPLICATIONS
  9. MARKET BY END-USER
    1. BLOOD BANKS/ BLOOD DONATION CENTERS
    2. HOSPITALS & CLINICS
    3. AMBULATORY SURGICAL CENTERS
  10. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. AUSTRALIA & NEW ZEALAND
        5. SOUTH KOREA
        6. INDONESIA
        7. THAILAND
        8. VIETNAM
        9. REST OF ASIA-PACIFIC
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ASAHI KASEI CORPORATION
      2. BAXTER INTERNATIONAL INC
      3. B BRAUN MELSUNGEN AG
      4. CERUS CORPORATION
      5. CYTOSORBENTS CORPORATION
      6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
      7. HAEMONETICS CORPORATION
      8. HEMACARE CORPORATION
      9. INFOMED
      10. KANEKA CORPORATION
      11. KAWASUMI LABORATORIES INC
      12. MEDICAP CLINIC GMBH
      13. MEDICA SPA
      14. MILTENYI BIOTEC
      15. TERUMO CORPORATION (TERUMO BCT)
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - APHERESIS

TABLE 2: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: LEADING PLAYERS OPERATING IN ASIA-PACIFIC APHERESIS MARKET

TABLE 15: LIST OF MERGERS & ACQUISITIONS

TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, IN 2020

FIGURE 6: ASIA-PACIFIC APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 12: ASIA-PACIFIC APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, IN 2020

FIGURE 15: ASIA-PACIFIC APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, IN 2020

FIGURE 18: ASIA-PACIFIC APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: PREVALENCE OF BLEEDING DISORDER IN ASIA-PACIFIC, 2019

FIGURE 20: ASIA-PACIFIC APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, IN 2020

FIGURE 25: ASIA-PACIFIC APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: CHINA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: JAPAN APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: INDIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: AUSTRALIA & NEW ZEALAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: SOUTH KOREA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: INDONESIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: THAILAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: VIETNAM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: REST OF ASIA-PACIFIC APHERESIS MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample